Current Ratio in % of Cartesian Therapeutics, Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cartesian Therapeutics, Inc. quarterly Current Ratio history and change rate from Q1 2017 to Q3 2025.
  • Cartesian Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1113%, a 205% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Cartesian Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1113% +748% +205% 30 Sep 2025
Q2 2025 1109% +833% +302% 30 Jun 2025
Q1 2025 884% +615% +229% 31 Mar 2025
Q4 2024 636% +330% +107% 31 Dec 2024
Q3 2024 365% -130% -26% 30 Sep 2024
Q2 2024 276% -267% -49% 30 Jun 2024
Q1 2024 269% -298% -53% 31 Mar 2024
Q4 2023 307% -194% -39% 31 Dec 2023
Q3 2023 495% +136% +38% 30 Sep 2023
Q2 2023 543% +295% +119% 30 Jun 2023
Q1 2023 567% +366% +182% 31 Mar 2023
Q4 2022 501% +317% +172% 31 Dec 2022
Q3 2022 359% +178% +98% 30 Sep 2022
Q2 2022 249% +53% +27% 30 Jun 2022
Q1 2022 201% -2.6% -1.3% 31 Mar 2022
Q4 2021 184% -30% -14% 31 Dec 2021
Q3 2021 181% -61% -25% 30 Sep 2021
Q2 2021 196% -33% -15% 30 Jun 2021
Q1 2021 204% +4.9% +2.5% 31 Mar 2021
Q4 2020 215% +32% +17% 31 Dec 2020
Q3 2020 242% +102% +72% 30 Sep 2020
Q2 2020 229% +80% +53% 30 Jun 2020
Q1 2020 199% +5.5% +2.8% 31 Mar 2020
Q4 2019 183% -80% -31% 31 Dec 2019
Q3 2019 141% -291% -67% 30 Sep 2019
Q2 2019 150% -600% -80% 30 Jun 2019
Q1 2019 194% -555% -74% 31 Mar 2019
Q4 2018 263% -441% -63% 31 Dec 2018
Q3 2018 432% -219% -34% 30 Sep 2018
Q2 2018 750% +99% +15% 30 Jun 2018
Q1 2018 749% -9% -1.2% 31 Mar 2018
Q4 2017 705% 31 Dec 2017
Q3 2017 651% 30 Sep 2017
Q2 2017 651% 30 Jun 2017
Q1 2017 758% 31 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.